Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints? - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles AIDS. Official journal of the international AIDS Society Year : 2013

Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints?

Domains

Quantitative Methods [q-bio.QM] Bioinformatics [q-bio.QM]

Rodolphe Thiébaut  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00933696

Submitted on : Monday, January 20, 2014-10:33:30 PM

Last modification on : Wednesday, March 15, 2023-8:50:07 AM

Consult the full text

Dates and versions

inserm-00933696 , version 1 (20-01-2014)

Identifiers

Cite

Laura Richert, Rodolphe Thiébaut. Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints?. AIDS. Official journal of the international AIDS Society, 2013, 27 (8), pp.1362-5. ⟨10.1097/QAD.0b013e328360d52e⟩. ⟨inserm-00933696⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM INRIA INRIA2
84 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More